Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Fetal Hemoglobin a Key for Improvement of Hypoxia and Saving Last Breath in COVID-19 Patient?. A Pilot Study.

NCT05092724 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT05092724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05092724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Fetal Hemoglobin a Key for Improvement of Hypoxia and Saving Last Breath in COVID-19 Patient?. A Pilot Study.
Lead sponsor
Zagazig University
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2021
Completion date
March 31, 2022
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 acute respiratory distress syndrome